News Breaks |
|
|
| January 9, 2013 |
| 16:22 EDT |  | BAYRY | Bayer's Skyla pregnancy prevention system approved by FDA
Bayer announced that the FDA approved Skyla (levonorgestrel-releasing intrauterine system) 13.5 mg, a new hormone-releasing system that is placed in the uterus for the prevention of pregnancy for up to three years. Skyla is a small, flexible plastic T-shaped device containing 13.5 mg of a progestin hormone called levonorgestrel. Skyla is intended for long-term use for up to three years but may be removed by a healthcare provider at any time. |
|
|
News For BAYRY From The Last 14 Days Check below for free stories on BAYRY the last two weeks. |
|
|
| May 20, 2013 |
| 17:20 EDT | | BAYRY | Regeneron,, Bayer, Genentech resolve certain patent disputes
 Subscribe for More Information |
|
| 07:28 EDT |  | BAYRY | American Thoracic Society to hold a conference
Subscribe for More Information |
|
| May 17, 2013 |
| 06:33 EDT | | BAYRY | American Thoracic Society to hold a conference
Subscribe for More Information |
|
| May 15, 2013 |
| 11:43 EDT | | BAYRY | Bayer announces FDA approval for Xofigo as CRPC treatment
Subscribe for More Information |
|
| May 7, 2013 |
| 17:25 EDT | | BAYRY | Bayer commences cash tender offer for Conceptus shares
Subscribe for More Information |
|
|
|
|
|
